Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure

Biometrical Journal

Volumn 49, Issue 3, 2007, Pages 351-364

  Srivastava, Deo Kumar ^a   Rai, Shesh N ^a   Pan, Jianmin ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Binary outcome; Group sequential; Odds ratio; Stratification

Indexed keywords

MEDICAL APPLICATIONS; STATISTICAL METHODS;

BINARY OUTCOME; EFFECT SIZE; GROUP SEQUENTIAL; INTERIM ANALYSIS; ODD RATIOS; OUTCOME MEASURES; RATIO TEST; RESPONSE RATE; STRATIFICATION; TREATMENT GROUP;

PROBABILITY DISTRIBUTIONS;

EID: 34547278060     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200610265     Document Type: Article

References (26)

1. Albert, J. M., Gadbury, G. L., and Mascha M. J. (2005). Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes. Biometrical Journal 47, 662-673.
2. Berger, V. W. (1998). Admissibility of exact conditional tests of stochastic order. Journal of Statistical Planning and Inference 66, 39-50.
3. Berger, V. W., Ivanova, A. and Knoll, M. D. (2003). Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Statistics in Medicine 22, 3017-3028.
4. Breslow, N. E. (1981). Odds ratio estimators when the data are sparse. Biometrika 68, 73-84.
5. Breslow, N. E. and Liang, K. Y. (1982). The variance of the Mantel-Haenszel estimator. Biometrics 38, 943-952.
6. Breslow, N. E. and Liang, K. Y. (1984). Correction to "The variance of the Mantel-Haenszel estimator." Biometrics 40, 1217.
7. Denis, L., Norlén, J., Holmberg, L., Begg, C. B., Damber, J. E., and Wilt, T. J. (1997). Planning controlled clinical trial. Urology 49, (supplement 4A), 15-26.
8. East (2000). Software for the Design and Interim Monitoring of Group Sequential Clinical Trials. User Manual. CYTEL Software Corporation, Cambridge, MA.
9. Fergusson, D., Aaron S. D., Guyatt G., and Hébert, P. (2002). Post-randomization exclusions: the intention to treat principle and excluding patients from analysis. British Medical Journal 325, 652-654.
10. Gillings, D. and Koch, G. (1991). The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Information Journal 25, 411-424.
11. Gould, A. L. (1992). Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. Statistics in Medicine 11, 55-66.
12. Gould, A. L. (2001). Sample size re-estimation: recent developments and practical considerations. Statistics in Medicine 20, 2625-2643.
13. Hauck, W. W. (1979). The large sample variance of the Mantel-Haenszel estimator of a common odds ratio. Biometrics 35, 817-819.
14. Jennison, C. and Turnbull, B. W. (1991). A note on the asymptotic joint distribution of successive Mantel-Haenszel estimates of the odds ratio based on accumulating data. Sequential Analysis 10, 201-209.
15. Jennison, C. and Turnbull, B. W. (2000). Group Sequential Methods with Applications to Clinical Trials. Chapman and Hall/CRC, New York.
16. Mantel, N. and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22, 719-748.
17. Newell, D. J. (1992). Intention-to-treat analysis: Implications for quantitative and qualitative research. International Journal of Epidemiology 21, 837-841.
18. O'Brien P. C. and Fleming T. R. (1979). A multiple testing procedure for clinical trials. Biometrics 35, 549-556.
19. Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika 64, 191-199.
20. Robins J., Breslow N., and Greenland S. (1986). Estimators of the Mantel-Haenszel variance consistent in both sparse-data and large strata limiting models. Biometrics 42, 311-323.
21. Shih W. J. (2001). Sample Size Re-estimation Journey for a Decade. Statistics in Medicine 20, 515-518.
22. Wang, S. K. and Tsiatis, A. A. (1987). Approximately optimal one-parameter boundaries for group seqential trials. Biometrics 43, 193-200.
23. Whitehead J. (1997). The Design and Analysis of Sequential Clinical Trials. Wiley, New York.
24. Whitehead J., Whitehead A., Todd S., Bolland K., and Sooriyarachchi M. R. (2001). Mid-trial design reviews for sequential clinical trials, Statistics in Medicine 20, 165-176.
25. Wittes J. and Brittain E. (1990). The role of internal pilot studies in increasing the efficiency of clinical trials, Statistics in Medicine 9, 65-72.
26. Zelen M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic Diseases 27, 365-375.